126 related articles for article (PubMed ID: 38359367)
21. Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.
Rani L; Gogia A; Singh V; Kumar L; Sharma A; Kaur G; Gupta R
Ann Hematol; 2019 Feb; 98(2):437-443. PubMed ID: 30338367
[TBL] [Abstract][Full Text] [Related]
22. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
[TBL] [Abstract][Full Text] [Related]
24. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA
Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771
[TBL] [Abstract][Full Text] [Related]
25. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.
Ferrajoli A; Shanafelt TD; Ivan C; Shimizu M; Rabe KG; Nouraee N; Ikuo M; Ghosh AK; Lerner S; Rassenti LZ; Xiao L; Hu J; Reuben JM; Calin S; You MJ; Manning JT; Wierda WG; Estrov Z; O'Brien S; Kipps TJ; Keating MJ; Kay NE; Calin GA
Blood; 2013 Sep; 122(11):1891-9. PubMed ID: 23821659
[TBL] [Abstract][Full Text] [Related]
27. Clinical aspects of monoclonal B-cell lymphocytosis.
Mowery YM; Lanasa MC
Cancer Control; 2012 Jan; 19(1):8-17. PubMed ID: 22143058
[TBL] [Abstract][Full Text] [Related]
28. Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients.
Hu B; Patel KP; Chen HC; Wang X; Luthra R; Routbort MJ; Kanagal-Shamanna R; Medeiros LJ; Yin CC; Zuo Z; Ok CY; Loghavi S; Tang G; Tambaro FP; Thompson P; Burger J; Jain N; Ferrajoli A; Bose P; Estrov Z; Keating M; Wierda WG
Br J Haematol; 2019 Nov; 187(3):307-318. PubMed ID: 31243771
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
Ojha J; Secreto C; Rabe K; Ayres-Silva J; Tschumper R; Dyke DV; Slager S; Fonseca R; Shanafelt T; Kay N; Braggio E
Leukemia; 2014 Dec; 28(12):2395-8. PubMed ID: 25034147
[No Abstract] [Full Text] [Related]
30. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
[TBL] [Abstract][Full Text] [Related]
31. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
32. Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.
Criado I; Muñoz-Criado S; Rodríguez-Caballero A; Nieto WG; Romero A; Fernández-Navarro P; Alcoceba M; Contreras T; González M; Orfao A; Almeida J;
Haematologica; 2017 Jul; 102(7):1238-1246. PubMed ID: 28385786
[TBL] [Abstract][Full Text] [Related]
33. [Monoclonal B-cell lymphocytosis: from literature to laboratory practice].
Keutgens A; Foguenne J; Gothot A; Tassin F
Ann Biol Clin (Paris); 2016; 74(2):168-75. PubMed ID: 27029722
[TBL] [Abstract][Full Text] [Related]
34. Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.
Siddon AJ; Rinder HM;
Am J Clin Pathol; 2013 Jun; 139(6):708-12. PubMed ID: 23690112
[TBL] [Abstract][Full Text] [Related]
35. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).
Rawstron AC; Shanafelt T; Lanasa MC; Landgren O; Hanson C; Orfao A; Hillmen P; Ghia P
Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S19-23. PubMed ID: 20839333
[TBL] [Abstract][Full Text] [Related]
36. HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.
García-Álvarez M; Alcoceba M; López-Parra M; Puig N; Antón A; Balanzategui A; Prieto-Conde I; Jiménez C; Sarasquete ME; Chillón MC; Gutiérrez ML; Corral R; Alonso JM; Queizán JA; Vidán J; Pardal E; Peñarrubia MJ; Bastida JM; García-Sanz R; Marín L; González M
PLoS One; 2017; 12(3):e0172978. PubMed ID: 28249016
[TBL] [Abstract][Full Text] [Related]
37. BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL).
Nasr AA; Fund X; Barreau S; Desterke C; Borie C; Oudrhiri N; Faivre J; Bennaceur-Griscelli A; Turhan AG
Leuk Lymphoma; 2024 May; 65(5):692-695. PubMed ID: 38293748
[No Abstract] [Full Text] [Related]
38. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
[TBL] [Abstract][Full Text] [Related]
39. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
[TBL] [Abstract][Full Text] [Related]
40. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
Slager SL; Lanasa MC; Marti GE; Achenbach SJ; Camp NJ; Abbasi F; Kay NE; Vachon CM; Cerhan JR; Johnston JB; Call TG; Rabe KG; Kleinstern G; Boddicker NJ; Norman AD; Parikh SA; Leis JF; Banerji V; Brander DM; Glenn M; Ferrajoli A; Curtin K; Braggio E; Shanafelt TD; McMaster ML; Weinberg JB; Hanson CA; Caporaso NE
Blood; 2021 Apr; 137(15):2046-2056. PubMed ID: 33512457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
